Arcutis Biotherapeutics I... (ARQT)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
13.75
0.47 (3.54%)
At close: Jan 15, 2025, 11:59 AM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 88.40M | 53.64M | 96.45M | 65.08M | 63.34M | 39.39M | 3.42M |
Short-Term Investments | 183.46M | 355.95M | 290.61M | 219.36M | 37.93M | 11.55M | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 596.00K | 78.00K | 78.00K | 78.00K | 47.00K | n/a | n/a |
Receivables | 25.81M | 8.46M | n/a | 510.00K | n/a | n/a | n/a |
Inventory | 13.13M | 7.51M | 1.18M | -510.00K | n/a | n/a | n/a |
Other Current Assets | 19.63M | 11.85M | 15.71M | 7.88M | 5.21M | 40.00K | 221.00K |
Total Current Assets | 330.43M | 437.41M | 402.77M | 292.83M | 106.47M | 51.10M | 3.82M |
Property-Plant & Equipment | 3.90M | 4.60M | 5.30M | 5.37M | 491.00K | n/a | n/a |
Goodwill & Intangibles | 6.44M | 7.19M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 10.93M | 11.87M | 5.38M | 5.44M | 538.00K | n/a | n/a |
Total Assets | 341.37M | 449.27M | 408.15M | 298.27M | 107.01M | 51.10M | 3.82M |
Account Payables | 11.99M | 8.83M | 7.35M | 7.14M | 1.41M | 1.80M | 537.00K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 735.00K | 1.31M | 866.00K | n/a | 356.00K | n/a | n/a |
Other Current Liabilities | 33.94M | 27.67M | 25.11M | 15.46M | 3.48M | 872.00K | 155.00K |
Total Current Liabilities | 46.67M | 37.81M | 33.33M | 22.60M | 5.24M | 2.67M | 692.00K |
Long-Term Debt | 205.18M | 201.89M | 77.12M | 4.96M | 129.00K | n/a | 966.00K |
Other Long-Term Liabilities | 849.00K | n/a | 25.00K | 82.00K | 166.68M | 72.41M | 7.15M |
Total Long-Term Liabilities | 206.03M | 201.89M | 77.15M | 5.05M | 166.80M | 72.41M | 8.12M |
Total Liabilities | 252.70M | 239.69M | 110.47M | 27.65M | 172.04M | 75.08M | 8.81M |
Total Debt | 205.92M | 202.54M | 77.56M | 4.96M | 307.00K | n/a | 966.00K |
Common Stock | 9.00K | 6.00K | 5.00K | 4.00K | n/a | n/a | n/a |
Retained Earnings | -981.90M | -719.76M | -408.31M | -201.95M | -66.27M | -24.28M | -5.02M |
Comprehensive Income | 4.00K | -1.09M | -255.00K | -2.00K | -1K | n/a | n/a |
Shareholders Equity | 88.67M | 209.58M | 297.68M | 270.62M | -65.03M | -23.99M | -4.99M |
Total Investments | 183.46M | 355.95M | 290.61M | 219.36M | 37.93M | 11.55M | n/a |